Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Hutton ScottPresident & CEO | BiodesixBDSX | Open-market sale | 02/23 | 02/23 | 1,490 sh | $12.78 | $19,042.2 | −3.0% |
Cowie Robin HarperCFO, Sec'y & Treasurer | BiodesixBDSX | Open-market sale | 02/23 | 02/23 | 535 sh | $12.78 | $6,837.3 | −3.2% |
Pestano Gary AnthonyChief Development Officer | BiodesixBDSX | Open-market sale | 02/23 | 02/23 | 556 sh | $12.78 | $7,105.68 | −5.1% |
O'Kane KieranChief Commercial Officer | BiodesixBDSX | Open-market sale | 02/23 | 02/23 | 535 sh | $12.78 | $6,837.3 | −5.2% |
Chris VazquezChief Accounting Officer | BiodesixBDSX | Open-market sale | 02/23 | 02/23 | 211 sh | $12.78 | $2,696.58 | −11.7% |
Hutton ScottPresident & CEO | BiodesixBDSX | Open-market sale | 02/10 | 02/11 | 3,559 sh | $10.08 | $35,874.72 | −7.3% |
Cowie Robin HarperCFO, Sec'y & Treasurer | BiodesixBDSX | Open-market sale | 02/10 | 02/11 | 941 sh | $10.08 | $9,485.28 | −5.8% |
Pestano Gary AnthonyChief Development Officer | BiodesixBDSX | Open-market sale | 02/10 | 02/11 | 540 sh | $10.08 | $5,443.2 | −5.4% |
O'Kane KieranChief Commercial Officer | BiodesixBDSX | Open-market sale | 02/10 | 02/11 | 584 sh | $10.08 | $5,886.72 | −6.2% |
Chris VazquezChief Accounting Officer | BiodesixBDSX | Open-market sale | 02/10 | 02/11 | 101 sh | $10.08 | $1,018.08 | −7.6% |
BiodesixBDSX | Open-market buy | 01/23–01/26 | 01/27 | 100,000 sh2 trades | $11.81avg. | $1,180,800 | +6.8% | |
Jack W. Schuler10% Owner | BiodesixBDSX | Open-market buy | 01/22 | 01/26 | 82,465 sh | $10.96 | $903,816.4 | +6.0% |
Hutton ScottPresident & CEO | BiodesixBDSX | Open-market sale | 01/16 | 01/20 | 970 sh | $8.15 | $7,905.5 | −2.4% |
Cowie Robin HarperCFO, Sec'y & Treasurer | BiodesixBDSX | Open-market sale | 01/16 | 01/20 | 298 sh | $8.15 | $2,428.7 | −2.1% |
Pestano Gary AnthonyChief Development Officer | BiodesixBDSX | Open-market sale | 01/16 | 01/20 | 298 sh | $8.15 | $2,428.7 | −3.4% |
O'Kane KieranChief Commercial Officer | BiodesixBDSX | Open-market sale | 01/16 | 01/20 | 298 sh | $8.15 | $2,428.7 | −3.6% |
Chris VazquezChief Accounting Officer | BiodesixBDSX | Open-market sale | 01/16 | 01/20 | 83 sh | $8.15 | $676.45 | −7.2% |
Hutton ScottPresident & CEO | BiodesixBDSX | Open-market sale | 25/11/10 | 25/11/13 | 189 sh | $7.62 | $1,440.18 | −0.5% |
Cowie Robin HarperCFO, Sec'y & Treasurer | BiodesixBDSX | Open-market sale | 25/11/10 | 25/11/13 | 50 sh | $7.62 | $381 | −0.4% |
Pestano Gary AnthonyChief Development Officer | BiodesixBDSX | Open-market sale | 25/11/10 | 25/11/13 | 23 sh | $7.62 | $175.26 | −0.3% |